60 results
Page 2 of 3
6-K
EX-99.1
jcqlc2qjqwugqumn1r
8 Dec 20
Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition
3:19pm
6-K
EX-99.1
3ts2ggwj
10 Nov 20
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
8:23am
6-K
EX-99.1
bd06wli5ai9x
5 Nov 20
Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting
10:36am
6-K
EX-99.3
ap2q6wptsu bty2
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.1
mfu iv08tn0i
13 Jul 20
Gamida Cell Announces Appointment of David Fox to Its Board of Directors
4:10pm
6-K
EX-99.1
tsvunay4jmx ujx
21 May 20
Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update
8:40am
424B5
n1q48k 52mmh
20 May 20
Prospectus supplement for primary offering
4:08pm
424B5
xo5fvc9avq215roh9a
18 May 20
Prospectus supplement for primary offering
4:11pm
6-K
EX-99.1
9po5 8kzchz33a7c
25 Feb 20
Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update
5:08pm
6-K
EX-99.1
3fy8uj0ak 92cw95
13 Jan 20
Gamida Cell Announces 2020 Goals and Provides Company Update
5:00pm
6-K
EX-99.1
od47uocxh9
9 Dec 19
Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting
3:30pm
F-3
msntuoz
14 Nov 19
Shelf registration (foreign)
5:11pm
6-K
EX-99.2
2nv89h14s41x
13 Nov 19
Report of Foriegn Private Issuer
5:18pm
6-K
EX-99.3
ut0vi
13 Nov 19
Report of Foriegn Private Issuer
5:18pm
6-K
EX-99.1
89g9atzh2flk8en5k4kq
7 Aug 19
Current report (foreign)
1:58pm
6-K
EX-99.2
cckwf0fyo30f54kwl7dp
7 Aug 19
Current report (foreign)
1:58pm
424B4
8nrfp
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
b8ej9vrs03
26 Jun 19
Registration statement (foreign) (amended)
12:00am